Eyenovia, Inc. announced on January 28, 2025, that its Board of Directors approved a 1-for-80 reverse stock split of its outstanding common stock. This action is within the ratio range approved by stockholders at a special meeting on January 21, 2025.
The Reverse Stock Split will become effective at 4:00 p.m., Eastern Time, on January 31, 2025. Trading on a post-split basis under the existing ticker symbol 'EYEN' will commence on February 3, 2025.
The primary purpose of the Reverse Stock Split is to enable Eyenovia to regain compliance with the minimum bid price required to maintain its listing on the Nasdaq Capital Market. The number of outstanding shares will be reduced from approximately 167.5 million to approximately 2.1 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.